BioCanvas
표적 · AADACL1

AADACL1 항체

1최다 인용
25인용된 항체
14벤더
Antibody Registry데이터 출처 · RRID CC0

논문 인용순 항체

Antibody Registry 인용수 기준 · 25종
1
Atlas Antibodies#HPA026888 RRID:AB_10601557 unknown
1
cited by
2
Novus#NB100-93363 RRID:AB_1236591 polyclonal
0
cited by
3
Everest Biotech#EB08327 RRID:AB_1248998 polyclonal
0
cited by
4
Novus#NBP1-00146 RRID:AB_1502527 polyclonal
0
cited by
5
RayBiotech#ER-14-0066 RRID:AB_1543218 unknown
0
cited by
6
Abcam#ab77486 RRID:AB_1565793 polyclonal
0
cited by
7
Abnova#PAB7510 RRID:AB_1570780 polyclonal
0
cited by
8
IMGENEX#IMX-30701 RRID:AB_1929682 unknown
0
cited by
9
ProSci#46-619 RRID:AB_1944884 polyclonal
0
cited by
10
Proteintech#14021-1-AP RRID:AB_2034888 polyclonal
0
cited by
11
Creative Diagnostics#CPBT-26006GH RRID:AB_2360059 unknown
0
cited by
12
Creative Diagnostics#CPBT-26014RM RRID:AB_2360067 unknown
0
cited by
13
Thermo Fisher Scientific#PA5-50285 RRID:AB_2635738 polyclonal
0
cited by
14
Thermo Fisher Scientific#PA5-55453 RRID:AB_2644513 polyclonal
0
cited by
15
ABclonal#A17741 RRID:AB_2770531 polyclonal
0
cited by
16
Thermo Fisher Scientific#PA5-107189 RRID:AB_2817905 polyclonal
0
cited by
17
Thermo Fisher Scientific#PA5-107190 RRID:AB_2817906 polyclonal
0
cited by
18
Affinity Biosciences#DF13688 RRID:AB_2846707 unknown
0
cited by
19
Thermo Fisher Scientific#PA5-114796 RRID:AB_2899432 polyclonal
0
cited by
20
Novus#NBP2-76805 RRID:AB_3404105 polyclonal
0
cited by
21
Novus#NBP2-86930 RRID:AB_3428316 polyclonal
0
cited by
22
Novus#NBP2-92379 (also NBP2-92379-0.02ml, NBP2-92379-0.1ml) RRID:AB_3462284 polyclonal
0
cited by
23
Novus#NBP3-17795 (also NBP3-17795-100ul) RRID:AB_3600902 polyclonal
0
cited by
24
Aladdin Scientific#Ab086897 RRID:AB_3696624 polyclonal
0
cited by
25
Proteintech#87679-2-RR RRID:AB_3745693 recombinant
0
cited by
이 표적 항체를 국내 공급가·납기로 확인하시겠어요? 국내 구매·견적 문의 →

AADACL1

이 표적에 논문에서 가장 많이 인용된 항체 순으로 정리했습니다. 각 행에서 국내 견적을 요청할 수 있습니다.

Data: Antibody Registry (SciCrunch) — RRID under CC-0; product metadata per respective source. Citation counts: Antibody Registry.